tm logo
Trademark Search
EMPOWER CBD, THE REVERSE GATEWAY DRUG
EMPOWER CBD, THE REVERSE GATEWAY DRUG
REGISTERED

on 06 Jul 2022

Last Applicant/ Owned by

EMPOWERPHARM INC.

5575 North Service RoadSuite 603Burlington

ONTARIO

CA

L7L6M1

Serial Number

1940830 filed on 15th Jan 2019

Registration Number

TMA1133518 registered on 06th Jul 2022

Registration expiry Date

06th Jul 2032

Correspondent Address

SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO

ONTARIO

CA

M5H3Y2

EMPOWER CBD, THE REVERSE GATEWAY DRUG

Trademark usage description

cannabidiol (cbd) in combination with natural health products namely glucosamine, turmeric supplements, digestive health supplements, melatonin, sleep Read More

Classification Information


Class [005]
Cannabidiol (CBD) in combination with natural health products namely glucosamine, turmeric supplements, digestive health supplements, melatonin, sleep support supplements; cannabidiol (CBD) for medical use in combination with over the counter medications for treating aches, pains, headaches, arthritis pain, sprains, for treatment of minor joint injuries and muscle soreness, and motion sickness; cannabidiol (CBD) for medical use in combination with nonsteroidal anti-inflammatory drugs (NSAIDs), ibuprofen, naproxen sodium, acetaminophen, and dimenhydrinate; cannabidiol (CBD) for medical purposes in the form of suppositories, sublingual doses that dissolve in the mouth, creams, ointments, and doses for absorption in the mucous membranes; tablets, capsules, skin patches, extended release tablets and liquids for therapeutic purposes containing cannabidiol (CBD); Cannabidiol (CBD) for medical purposes; herbal supplements containing cannabidiol (CBD); Liquid nutritional supplement containing cannabidiol (CBD) for treating, reducing or improving symptoms of various conditions, namely, pain, anxiety, depression, cancer, acne, skin conditions, neuroprotection, cardiovascular health, arthritis, inflammation, autoimmune conditions, epileptic seizures, nausea, appetite, inflammatory bowel disease, and insomnia; tetrahydrocannabinol (THC) for medical purposes; tetrahydrocannabinol (THC) for medical purposes in sublingual doses and doses for absorption in the mucous membranes; tablets, capsules, gummies, suppositories, skin patches, sublingual doses, extended release tablets and liquid for therapeutic purposes containing tetrahydrocannabinol (THC), and containing a combination of tetrahydrocannabinol (THC) together with cannabidiol (CBD); medicinal cannabis; medicinal marijuana.


Classification kind code

11

Mark Details


Serial Number

1940830

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 15th Jun 2022
Registration Pending
Submitted for opposition 191
on 15th Jun 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 23rd Mar 2022
Advertised
Submitted for opposition 26
on 21st Jan 2022
Approved
Submitted for opposition 27
on 21st Jan 2022
Approval Notice Sent
Submitted for opposition 22
on 07th Oct 2020
Search Recorded
Submitted for opposition 20
on 07th Oct 2020
Examiner's First Report
Submitted for opposition 31
on 18th Jan 2019
Formalized
Submitted for opposition 1
on 16th Jan 2019
Created
Submitted for opposition 30
on 15th Jan 2019
Filed